Business News

Roche-Ttrials-121914.jpgRoche said it was halting a late-stage trial of its investigational drug gantenerumab to treat patients with early Alzheimer's disease as its overall safety profile was similar to that of a Phase 1 study.

FDA Approves AstraZeneca's Lynparza To Treat Advanced Ovarian Cancer

British drugmaker AstraZeneca PLC (AZN, AZN.L) said Friday that the US Food and Drug Administration has approved Lynparza capsules, 400mg twice daily, as the first monotherapy for patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, who have been treated with...

Latest News


Carnival Q4 Adj. Profit Tops View, But Revenues Miss

Cruise operator Carnival Corp. & plc reported Friday a net loss for the fourth quarter compared to a profit last year, reflecting lower operating costs and revenue growth. Adjusted earnings per share topped analysts' expectation, while quarterly revenues missed their estimates.The company also provided earnings guidance for the first quarter and full-year 2015.

Mexico Jobless Rate At 11-month Low

Mexico's unemployment rate eased for the fourth successive month in November to its lowest level since the end of last year, figures from the statistical office INEGI showed Friday. The unadjusted jobless rate fell to 4.53 percent from 4.78 percent in October. Economists had expected a figure of 4.60...

Mexico Nov Jobless Rate S.a. 4.71% Vs. 4.73% In Oct, Consensus 4.66%

Mexico Nov Jobless Rate Unadj. 4.53% Vs. 4.78% In Oct, Consensus 4.60%

Canadian Retail Sales Relatively Unchanged In October


Sartorius To Sell Its Industrial Technologies Division To Japanese Minebea

Sartorius, a laboratory and pharmaceutical equipment provider, announced the sale of its Industrial Technologies Division or Intec to the Japanese Minebea Co., Ltd. and their partner, the Development Bank of Japan Inc. The sales price will be determined as a multiple of the Intec division's 2014 operating...

News Corp Acquires BigDecisions.Com In India


Finish Line Inc. (FINL) Fell To New Low On Disappointing Guidance

Finish Line Inc. (FINL) reported a third quarter non-GAAP loss of $0.02 per share Friday morning, down from the profit of $0.06 per share in the previous year. Analysts expected a profit of $0.01 per share. The company now expects full year 2015 non-GAAP EPS to be flat with the fiscal year 2014 non-GAAP...

Juno Therapeutics Prices IPO Above Range

Juno Therapeutics Inc, a biopharmaceuticals company, on Thursday priced its initial public offering of 11 million common shares at $24.00 each, above the expected range of $21 to $23 per share. Juno has granted the underwriters a 30-day option to purchase up to an additional abou 1.7 million shares...

Carnival Q4 14 Earnings Conference Call At 10:00 AM ET

Carnival Corp. (CCL) will host a conference call at 10:00 AM ET on December 19, 2014, to discuss Q4 14 earnings results. To access the live webcast log on to and